Media Room
First Quarter 2025
First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Thursday April 24, 2025
13:00 - 14:30 CEST (7:00am – 8:30am EDT)
Press releases
April 25, 2025
Media Update: Sanofi’s Foundation S and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program
April 24, 2025
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed
April 18, 2025
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
Registration Document 2024 (in French)
XBRL Viewer 20F 2024